期刊文献+

β,γ-不饱和酮酸酯与亚甲胺叶立德的[1,3]-偶极环加成反应

1,3-Dipolar Cycloaddition Reaction of Azomethine Ylide with β,γ-Unsaturated Keto esters
下载PDF
导出
摘要 运用β,γ-不饱和酮酸酯与亚甲胺叶立德的[1,3]-偶极环加成反应合成一系列恶唑烷类衍生物,在室温下就可以得到非常好的化学收率,最高收率达92%. oxazolidine derivatives were syntesized through [1,3]-dipolar cycloaddition reaction of β,γ-unsaturated ketoesters with azomethine ylide,generating in situ from N-(methoxymethyl)-N-(trimethylsilylmethyl) benzylamine,offering the 1,3-dipolar cycloaddition products in high yields.
出处 《西华师范大学学报(自然科学版)》 2014年第2期100-102,107,共4页 Journal of China West Normal University(Natural Sciences)
基金 国家自然科学基金(21102116) 四川省科技厅项目(2013JY0095)
关键词 β γ-不饱和酮酸酯 甲亚胺叶立德 [1 3]-偶极环加成反应 β γ-unsaturated keto esters azomethine ylide 1 3-dipolar cycloaddition reaction
  • 相关文献

参考文献8

  • 1M ONGE A ,ALDANA I, CERECETTO H,at al. Synthesis of New Oxazolidine Oxazolidin-2-one and Perhydro-1,4-Oxazine Deriv- atives of Arylethanolamine as Potential Beta3-Adrenoceptor Agonists [ J]. J. Heterocyclic Chem. 1995,32,1429 -1439.
  • 2卞如濂,魏尔清,唐法娣,等.复方喘敌素平喘抗过敏作用的观察[J].浙江医科大学学报,1987,16(3),104-109.
  • 3RYAN J H,HOLMES A B, et al. Synthesis of 5-Aryloxazolidines via 1,3-Dipolar Cycloaddition Reaction of a Non-Stabilized Azomethine Ylide with Aromatic Aldehydes[ J]. Aust. J. Chem. 2007, 60, 898 - 904.
  • 4HARWOOD L M, VICKERS R J, in Synthetic Applications of 1,3-Dipolar Cycloaddition Chemistry Toward Heterocycles and Natural Products [ J] Chem. Heterocyel. Compd. 2003,59,169 - 252.
  • 5ALBERT P,William D. On the Use of N-[ (T rimethylsilyl)methyl] amino Ethers as Capped Azomcthine Ylide Equivalents[J]. J. Org. Chem.,1987,52( 2),235-244.
  • 6JABLONSKI,PHILIPPE,..'et al. Preparation of Pyridinyloxyethylpyrrolidinyl Piperidinyl Methanones and Related Compounds as Neurokinin NK3 Receptor Antagonists [ P]. U.S. :20090306043,10 Dec 2009.
  • 7BIRD,PAUL,et al. Preparation of 3-Aminoquinazoline-2,4-Dione Antibacterial Agents [ P]. U.S. :2001053273,26 Jul 2001.
  • 8BARTON, JOHN P,et al. N-Aeylated-3-(Benzoyl)-Pyrrolidines as 11-Beta-HSD1 Inhibitors Useful for the Treatment of Meta- bolic Disorders [P]. U. S. :2005047250,26 May 2005.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部